• 00:00 1.
    Nocturia and Nocturnal Enuresis
  • 00:43 2.
    Slide 2
  • 01:08 3.
    Nocturia
  • 02:38 4.
    NOCTURNAL POLYURIA
  • 03:07 5.
    Circadian Urine Production
  • 03:31 6.
    Circadian ADH Production
  • 03:46 7.
    NOCTURIA TREATMENT OFTEN FAILS DUE TO QUESTIONABLE DIAGNOSTIC ASSUMPTIONS
  • 04:43 8.
    Poor results are observed with OAB/BPO therapy for nocturia treatment
  • 05:38 9.
    TURP FAILS TO IMPROVE NOCTURIA IN MEN
  • 06:39 10.
    UNDERLYING NOCTURAL POLYURIA (NP) IS THE REASON WHY α1-BLOCKER TREATMENT OFTEN FAILS TO TREAT NOCTURIA
  • 07:10 11.
    EVALUATION
  • 08:34 12.
    VALUE OF FVCS FOR APPROPRIATEDIAGNOSIS AND TREATMENT
  • 09:16 13.
    VOIDING DIARY ANALYSIS: CASE STUDIES
  • 12:07 14.
    Simple Algorithm for Classification and Treatment of Nocturia
  • 13:53 15.
    ManagementLifestyle modification
  • 15:06 16.
    ManagementLifestyle modification
  • 15:52 17.
    ManagementLifestyle modification
  • 16:23 18.
    WHAT IS DESMOPRESSIN?
  • 17:12 19.
    Desmopressin has Level 1b-Evidence andGrade A-Recommendation
  • 17:39 20.
    COMBINATION THERAPY
  • 18:07 21.
    Possible therapy combinations
  • 18:17 22.
    Poor results are observed with OAB/BPO therapy for nocturia treatment
  • 18:22 23.
    DESMOPRESSIN + α1 ANTAGONISTS DECREASE NOCTURIA AND IMPROVE IPSS SCORES IN PATIENTS WITH LUTS
  • 18:34 24.
    DESMOPRESSIN + LUTS AGENTS ARE AN EFFECTIVE TREATMENT FOR NOCTURIA IN PATIENTS WITH BPH
  • 18:56 25.
    DESMOPRESSIN + LUTS AGENTS ARE A WELL TOLERATED TREATMENT FOR NOCTURIA IN PATIENTS WITH BPH
  • 19:41 26.
    Practical Considerations for Desmopressin Use
  • 20:47 27.
    SUMMARY: CURRENT DIAGNOSIS AND TREATMENT RECOMMENDATIONS
  • 21:23 28.
    Nocturnal Enuresis
  • 21:43 29.
    Nocturnal Enuresis
  • 22:13 30.
    Quantification of Nocturnal Enuresis
  • 22:42 31.
    Subtypes of Nocturnal Enuresis
  • 23:12 32.
    Epidemiology of Nocturnal Enuresis
  • 23:41 33.
    Balance between Bladder capacity and Nocturnal urine vol
  • 23:45 34.
  • 23:54 35.
    Treatment of Nocturnal Enuresis
  • 24:30 36.
    DDAVP Therapy in Nocturnal Enuresis in Children
  • 24:56 37.
    Thanks for your attention
  • 索引
  • 筆記
  • 討論
  • 全螢幕
Nocturia and Nocturnal Enuresis
長度: 33:11, 瀏覽: 944, 最近修訂: 2017-05-19
    • 00:00 1.
      Nocturia and Nocturnal Enuresis
    • 00:43 2.
      Slide 2
    • 01:08 3.
      Nocturia
    • 02:38 4.
      NOCTURNAL POLYURIA
    • 03:07 5.
      Circadian Urine Production
    • 03:31 6.
      Circadian ADH Production
    • 03:46 7.
      NOCTURIA TREATMENT OFTEN FAILS DUE TO QUESTIONABLE DIAGNOSTIC ASSUMPTIONS
    • 04:43 8.
      Poor results are observed with OAB/BPO therapy for nocturia treatment
    • 05:38 9.
      TURP FAILS TO IMPROVE NOCTURIA IN MEN
    • 06:39 10.
      UNDERLYING NOCTURAL POLYURIA (NP) IS THE REASON WHY α1-BLOCKER TREATMENT OFTEN FAILS TO TREAT NOCTURIA
    • 07:10 11.
      EVALUATION
    • 08:34 12.
      VALUE OF FVCS FOR APPROPRIATEDIAGNOSIS AND TREATMENT
    • 09:16 13.
      VOIDING DIARY ANALYSIS: CASE STUDIES
    • 12:07 14.
      Simple Algorithm for Classification and Treatment of Nocturia
    • 13:53 15.
      ManagementLifestyle modification
    • 15:06 16.
      ManagementLifestyle modification
    • 15:52 17.
      ManagementLifestyle modification
    • 16:23 18.
      WHAT IS DESMOPRESSIN?
    • 17:12 19.
      Desmopressin has Level 1b-Evidence andGrade A-Recommendation
    • 17:39 20.
      COMBINATION THERAPY
    • 18:07 21.
      Possible therapy combinations
    • 18:17 22.
      Poor results are observed with OAB/BPO therapy for nocturia treatment
    • 18:22 23.
      DESMOPRESSIN + α1 ANTAGONISTS DECREASE NOCTURIA AND IMPROVE IPSS SCORES IN PATIENTS WITH LUTS
    • 18:34 24.
      DESMOPRESSIN + LUTS AGENTS ARE AN EFFECTIVE TREATMENT FOR NOCTURIA IN PATIENTS WITH BPH
    • 18:56 25.
      DESMOPRESSIN + LUTS AGENTS ARE A WELL TOLERATED TREATMENT FOR NOCTURIA IN PATIENTS WITH BPH
    • 19:41 26.
      Practical Considerations for Desmopressin Use
    • 20:47 27.
      SUMMARY: CURRENT DIAGNOSIS AND TREATMENT RECOMMENDATIONS
    • 21:23 28.
      Nocturnal Enuresis
    • 21:43 29.
      Nocturnal Enuresis
    • 22:13 30.
      Quantification of Nocturnal Enuresis
    • 22:42 31.
      Subtypes of Nocturnal Enuresis
    • 23:12 32.
      Epidemiology of Nocturnal Enuresis
    • 23:41 33.
      Balance between Bladder capacity and Nocturnal urine vol
    • 23:45 34.
    • 23:54 35.
      Treatment of Nocturnal Enuresis
    • 24:30 36.
      DDAVP Therapy in Nocturnal Enuresis in Children
    • 24:56 37.
      Thanks for your attention
    位置
    資料夾名稱
    2015臺大攝護祭-醫藥護人員場
    發表人
    系統管理者
    單位
    泌尿部
    建立
    2017-05-19 17:18:26
    最近修訂
    2017-05-19 19:53:15
    長度
    33:11